Physician
Providence Health & Services - Oregon
Providence Health & Services - Oregon was paid $19.48M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99285, emergency room visit (most serious) — 34% of everything it billed.
33Billing provider infoPROVIDENCE HEALTH & SERVICES - OREGON
OREGON CITY, OR 97045
OREGON CITY, OR 97045
33aNPI1912282369assigned 10/18/2011
33bProvider typeAnesthesiology Physician
28Total paid$19.48M
24GClaims247,201
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Oregon
Rank by total paid#5 of 43
Median peer was paid$94K
This provider vs. median208×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,397 | $3.65M | |
| 2019 | 39,157 | $2.93M | |
| 2020 | 31,813 | $2.36M | |
| 2021 | 28,501 | $1.97M | |
| 2022 | 32,049 | $2.68M | |
| 2023 | 37,027 | $3.02M | |
| 2024incomplete | 34,257 | $2.87M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 34% | 17,899 | 16,412 | $6.58M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 22,262 | 20,343 | $6.16M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 20,574 | 18,025 | $3.68M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9.0% | 15,821 | 14,450 | $1.76M |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 9,756 | 8,695 | $372K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 8,935 | 7,675 | $291K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 2,757 | 2,627 | $215K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,537 | 1,197 | $112K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,131 | 1,979 | $107K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,699 | 1,546 | $54K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 222 | 151 | $46K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 165 | 156 | $34K |
49 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 196 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 192 | $11K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,075 | $8K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 84 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 62 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 34,136 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,180 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 28 | $1K |
| 83690 | <1% | 8,918 | $1K | |
| 84484 | <1% | 5,919 | $999.66 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 243 | $800.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 96 | $674.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,187 | $500.70 |
| 81025 | <1% | 1,445 | $458.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 975 | $351.49 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 28 | $298.26 |
| 80305 | <1% | 535 | $266.00 | |
| 84145 | <1% | 1,782 | $241.99 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,045 | $239.47 |
| 83605 | <1% | 1,445 | $184.73 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 130 | $148.00 |
| 81001 | <1% | 1,960 | $141.54 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 126 | $141.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,206 | $139.38 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,228 | $82.07 |
| 85610 | <1% | 967 | $75.16 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,916 | $52.45 |
| 81003 | <1% | 937 | $46.00 | |
| 84703 | <1% | 713 | $31.50 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 75 | $12.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 236 | $9.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 5,278 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,309 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,006 | $0.00 |
| 87631 | 0% | 14 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 61 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 2,105 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 947 | $0.00 |
| 96376 | 0% | 124 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 55 | $0.00 |
| 83735 | 0% | 136 | $0.00 | |
| 83880 | 0% | 106 | $0.00 | |
| 87040 | 0% | 14 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 12 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 143 | $0.00 |
| 82803 | 0% | 14 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 16 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.